Prostate Biopsy: A Risk-Benefit Analysis

Journal of Urology

Volumn 183, Issue 3, 2010, Pages 852-853

  Loeb, Stacy ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; METRONIDAZOLE; PLACEBO; PROSTATE SPECIFIC ANTIGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; CANCER MORTALITY; CLINICAL PRACTICE; CLINICAL TRIAL; COST CONTROL; EDITORIAL; ESCHERICHIA COLI; HOSPITAL ADMISSION; HUMAN; MEDICAL SOCIETY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RISK BENEFIT ANALYSIS; TREATMENT DURATION; URINARY TRACT INFECTION;

BIOPSY; HUMANS; MALE; PROSTATE; RISK ASSESSMENT;

EID: 75849140087     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.12.063     Document Type: Editorial

References (10)

1. Chang P., and Friedland G.W. The role of imaging in screening for prostate cancer. A decision analysis perspective. Invest Radiol 25 (1990) 591
2. Litwin M.S., and Saigal C.S. Prostate cancer. Urologic Disease in America. National Institutes of Health Publication 07-5512. United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (2007), United States Government Publishing Office, Washington D. C 76
3. Ozden E., Bostanci Y., Yakupoglu K.Y., et al. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology 74 (2009) 119
4. Wolf Jr. J.S., Bennett C.J., Dmochowski R.R., et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179 (2008) 1379
5. Kapoor DA, Klimberg IW, Malek GH et al: Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 2998: 52: 552.
6. Aron M., Rajeev T.P., and Gupta N.P. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85 (2000) 682
7. Al-Hasan M.N., Lahr B.D., Eckel-Passow J.E., et al. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother 64 (2009) 169
8. Welch H.G., Fisher E.S., Gottlieb D.J., et al. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst 99 (2007) 1395
9. Walter L.C., Bertenthal D., Lindquist K., et al. PSA screening among elderly men with limited life expectancies. JAMA 296 (2006) 2336
10. Schroder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320